Navigation Links
United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China
Date:7/1/2010

SILVER SPRING, Md., July 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and Lee's Pharmaceutical Holdings Ltd. (HKEx: 0950) announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China.  Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension.  Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.

"We are delighted to work with Lee's Pharmaceutical as our exclusive partner to bring Remodulin to Chinese physicians and their patients," said Roger Jeffs, Ph.D., United Therapeutics' President and Chief Operating Officer.  "We believe that Remodulin will be an important addition to the currently available treatment options for PAH patients in China."

"We are excited to be United Therapeutics' partner in China for Remodulin," said Dr. Benjamin Li, Chief Executive Officer of Lee's Pharmaceutical. "We are proud to add this important product to our specialty pharmaceutical portfolio and are anxious to begin the cooperative work with United Therapeutics."

Under the terms of the distribution agreement, Lee's Pharmaceutical will be responsible for obtaining all necessary authorizations to market Remodulin in China, including conducting necessary bridging studies.  Upon receipt of marketing authorization and pricing a
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
2. Abt Bio-Pharma Solutions, Inc. Acquired by United BioSource Corporation
3. Scripps Announces Sale of United Medias Licensing Business for $175 Million
4. Peptimmune Announces Second Grant of a United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
5. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
6. The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors
7. The Worlds First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference
8. Actress and Singer, Cynthia Basinet Petitions United Nations
9. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
10. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
11. Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2015)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results ... fiscal 2014 year-end financial statements and MD&A have been filed on SEDAR ... , 2014 , 2013 Revenue 3,968 , ... 1,326 , 1,703 , 2,231 , ... 3,377 , 4,562 Ebitda* 92 , 418 ...
(Date:4/29/2015)... RUTHERFORD, N.J. , April 29, 2015 Cambrex ... financial results will be released on Friday, May 1, 2015 ... The Company will host a conference call ... Call When: , Friday, May ... , 1-888-468-2440 for U.S.1-719-325-2454 for International  Passcode:  ...
(Date:4/29/2015)... CA (PRWEB) April 29, 2015 The ... to announce that its regenerative stem cell therapy has ... in 2002, seeking to discover a successful treatment for ... , In 2003 VetStem signed a worldwide exclusive license ... application, and the first horse was treated in January ...
(Date:4/29/2015)... 29, 2015 /CNW/ - Northern Biologics Inc., a privately ... announced an exclusive, strategic collaboration with Celgene Corporation. ... a US$30 million upfront cash payment. It will ... therapeutic antibodies, and will have the right to ... of its portfolio. Under the ...
Breaking Biology Technology:Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples 2Northern Biologics and Celgene Enter Strategic Collaboration 2
... of Wisconsin-Madison spinout that has sped to the finals in ... stop to the annual flu vaccine hoopla, among other things. ... are developing two drugs based on antiviral peptides discovered in ... while the other targets some sexually transmitted viruses such as ...
... recent decision to pull Pfizer Cox-2 inhibitor Bextra from the marketplace ... up in the Merck Vioxx dilemma months ago and its stock ... $25 per share in February. It has recently moved up to ... about 30 percent in the last 12 months. , ,Though Pfizer ...
... Sensient Technologies Corp. (NYSE:SXT) reported $12.8 million ... quarter ended March 31. Diluted earnings per share were 27 ... flavors and fragrances. , ,Revenue was down $3 million since ... a reduction of $19.2 million. , ,Results for the first ...
Cached Biology Technology:UW-Madison spinoff Pedrus finds more to business planning than good science 2UW-Madison spinoff Pedrus finds more to business planning than good science 3Why are new drugs failing? 2Why are new drugs failing? 3Why are new drugs failing? 4Why are new drugs failing? 5Why are new drugs failing? 6
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... 2015 In the current ... outperforms the strongest competitors, showing outstanding performance in ... system is capable of a throughput of 5.000.000 ... to be ten times faster than most competitors ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... The University of Chicago Celiac Disease Center is hosting ... 22-25, 2013 in Chicago. The symposium is the largest ... The meeting, which follows the 2011 conference in Oslo, ... United States since 2006. The Chicago meeting seeks ...
... Paris, France, dedicated to improving human health through international ... grant award to a new global research network of ... Research Center at Icahn School of Medicine at Mount ... as part of the Fondation Leducq,s Transatlantic Networks of ...
... in a wide range of problems from arthritis to cardiovascular ... temper this problem. A new research report appearing in the ... , helps explain why DHA is important in reducing inflammation, ... will help bring people back to optimal health. Specifically, researchers ...
Cached Biology News:UChicago Celiac Disease Center to host international symposium 2Fondation Leducq awards $6 million grant for global research network for cardiac regeneration 2Fondation Leducq awards $6 million grant for global research network for cardiac regeneration 3Harvard and USC scientists show how DHA resolves inflammation 2
... Electron RapidStak provides valuable walk-away time and ... buffer nest technology for parallel processing of ... fast, reliable automation for any laboratory in ... The RapidStak can be set-up within minutes ...
... polyclonal to MLF1 Interacting Protein/PBIP1 (phospho ... tested applications). Antigen: ... amino acids 73-83 of Human MLF1 ... Gene ID: 359815 ...
... These handy dispensers save space ... hats, and other garb. They are ... small parts used in labs, processing ... static charges and the particles they ...
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Rice microRNA Microarray ...
Biology Products: